» Articles » PMID: 19404239

Intravaginal Gene Silencing Using Biodegradable Polymer Nanoparticles Densely Loaded with Small-interfering RNA

Overview
Journal Nat Mater
Date 2009 May 1
PMID 19404239
Citations 192
Authors
Affiliations
Soon will be listed here.
Abstract

Vaginal instillation of small-interfering RNA (siRNA) using liposomes has led to silencing of endogenous genes in the genital tract and protection against challenge from infectious disease. Although siRNA lipoplexes are easily formulated, several of the most effective transfection agents available commercially may be toxic to the mucosal epithelia and none are able to provide controlled or sustained release. Here, we demonstrate an alternative approach using nanoparticles composed entirely of FDA-approved materials. To render these materials effective for gene silencing, we developed novel approaches to load them with high amounts of siRNA. A single dose of siRNA-loaded nanoparticles to the mouse female reproductive tract caused efficient and sustained gene silencing. Knockdown of gene expression was observed proximal (in the vaginal lumen) and distal (in the uterine horns) to the site of topical delivery. In addition, nanoparticles penetrated deep into the epithelial tissue. This is the first report demonstrating that biodegradable polymer nanoparticles are effective delivery vehicles for siRNA to the vaginal mucosa.

Citing Articles

Biodistribution of Polymeric Nanoparticles following in utero Delivery to a Nonhuman Primate.

Eaton D, Lynn A, Surprenant J, Deschenes E, Guerra M, Rivero R Biomed Hub. 2025; 10(1):23-32.

PMID: 39845408 PMC: 11753793. DOI: 10.1159/000543138.


Exploring the therapeutic potential of sγPNA-141: Pharmacodynamics and mechanistic insights during ischemic stroke recovery.

Yadav S, Dhuri K, Gamiotea-Turro D, Cormier M, Patel V, Yadawa A Mol Ther Nucleic Acids. 2024; 35(4):102355.

PMID: 39507400 PMC: 11539414. DOI: 10.1016/j.omtn.2024.102355.


Polymeric Vehicles for Nucleic Acid Delivery: Enhancing the Therapeutic Efficacy and Cellular Uptake.

Gupta P, Sharma A, Mittal V Recent Adv Drug Deliv Formul. 2024; 18(4):276-293.

PMID: 39356099 DOI: 10.2174/0126673878324536240805060143.


Branching in poly(amine-co-ester) polyplexes impacts mRNA transfection.

Shin K, Suh H, Suberi A, Whang C, Ene M, Grundler J Biomaterials. 2024; 311:122692.

PMID: 38986360 PMC: 11298310. DOI: 10.1016/j.biomaterials.2024.122692.


RNAi-based drug design: considerations and future directions.

Tang Q, Khvorova A Nat Rev Drug Discov. 2024; 23(5):341-364.

PMID: 38570694 PMC: 11144061. DOI: 10.1038/s41573-024-00912-9.


References
1.
Palliser D, Chowdhury D, Wang Q, Lee S, Bronson R, Knipe D . An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection. Nature. 2005; 439(7072):89-94. DOI: 10.1038/nature04263. View

2.
Peer D, Park E, Morishita Y, Carman C, Shimaoka M . Systemic leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-inflammatory target. Science. 2008; 319(5863):627-30. PMC: 2490797. DOI: 10.1126/science.1149859. View

3.
Thomas T, Thomas T . Polyamines in cell growth and cell death: molecular mechanisms and therapeutic applications. Cell Mol Life Sci. 2001; 58(2):244-58. PMC: 11146526. DOI: 10.1007/PL00000852. View

4.
Hannon G, Rossi J . Unlocking the potential of the human genome with RNA interference. Nature. 2004; 431(7006):371-8. DOI: 10.1038/nature02870. View

5.
Kumar P, Ban H, Kim S, Wu H, Pearson T, Greiner D . T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice. Cell. 2008; 134(4):577-86. PMC: 2943428. DOI: 10.1016/j.cell.2008.06.034. View